Article

Testis-Specific Thioredoxins TXNDC2, TXNDC3, and TXNDC6 Are Expressed in Both Testicular…

Oxidative Medicine and Cellular Longevity · 2020 · Mikko C. Chan, author Janette Savela, author Riina K. Ollikainen, author Hanna-Riikka Teppo, author Ilkka Miinalainen, author Risto Pirinen, author Esa J. M. Kari, author Hanne Kuitunen, author Taina Turpeenniemi-Hujanen, author Outi Kuittinen, author Milla E. L. Kuusisto, author Luciana Mosca, Academic Editor

Key facts

Title Testis-Specific Thioredoxins TXNDC2, TXNDC3, and TXNDC6 Are Expressed in Both Testicular and Systemic DLBCL and Correlate with Clinical Disease Presentation
First author Mikko C. Chan, author Janette Savela, author Riina K. Ollikainen, author Hanna-Riikka Teppo, author Ilkka Miinalainen, author Risto Pirinen, author Esa J. M. Kari, author Hanne Kuitunen, author Taina Turpeenniemi-Hujanen, author Outi Kuittinen, author Milla E. L. Kuusisto, author Luciana Mosca, Academic Editor
Journal Oxidative Medicine and Cellular Longevity
Published Jul 7, 2020
DOI 10.1155/2021/8026941
Devices mentioned K810863
Product codes mentioned DBM

At a glance

  • 1–9 FDA submissions mentioned
  • 1–9 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature